Dario Launches Agreement With Large Regional Health Plan And Announces Preliminary Results For Q2 2023 As Well As Business Update; Sees Q2 Revenue $6M-$6.15M Vs $6.73M Est.; Preliminary Unaudited Cash And Cash Equivalents Of $52.6M As Of June 30
Portfolio Pulse from Happy Mohamed
DarioHealth Corp. (NASDAQ:DRIO) has announced a new agreement with a large regional health plan to provide digital health solutions to over 160,000 members. The company also released preliminary Q2 2023 results, with revenues between $6M-$6.15M, lower than the estimated $6.73M. The company's cash and cash equivalents stood at $52.6M as of June 30, 2023. Dario also announced strategic partnerships with MedOne Pharmacy Benefits Solution and Solera, which are expected to contribute to 2023 revenues.
July 24, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
DarioHealth's new agreement and strategic partnerships are positive developments, but lower-than-expected Q2 revenues may negatively impact the stock in the short term.
The new agreement and strategic partnerships indicate growth and expansion for DarioHealth, which is positive for the stock. However, the lower-than-expected Q2 revenues may cause some investor concern and could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100